MedTrace Logo

Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.

NCT01228630 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2016-04-11

No results posted yet for this study

Summary

The loratadine-pseudoephedrine combination has proven to be more effective than the use of these individual components. This prospective, randomized, double-blind and paralel study, in which patients with perennial allergic rhinitis receive one of loratadine + pseudoephedrine association drug for treatment of signs and symptoms during 4 weeks.

Conditions

  • Perennial Allergic Rhinitis

Interventions

DRUG

Cloratadd-D

The patients receive one pill of treatment every 12 hours ( to get up and going to bed), of a glass of water.

DRUG

Allegra-D

The patients receive one pill of treatment every 12 hours ( to get up and going to bed), of a glass of water.

Sponsors & Collaborators

  • EMS S/A

    collaborator UNKNOWN

  • Azidus Brasil

    lead INDUSTRY

Principal Investigators

  • Luiz Tikara Shimizu, PI · LAL Clinica Pesquisa e Desenvolvimento Ltda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-04-30
Completion
2012-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01228630 on ClinicalTrials.gov